Free shipping on orders over $150

GROWTH · PEPTIDE BLEND

What is GHRP-6 + Mod GRF 1-29?

Medically reviewed by the G1 Peptides clinical team · Updated October 1, 2026

THE SHORT ANSWER

A GHRP-6 and Mod GRF 1-29 blend combines two growth hormone secretagogues. GHRP-6 acts on the ghrelin receptor and Mod GRF 1-29 on the GHRH receptor, producing a strong pulse of growth hormone release.

GHRP-6 + Mod GRF 1-29 at a glance

Type
Peptide blend
Also known as
GHRP-6 + CJC-1295 no DAC
Mechanism
GHRP-6 (ghrelin receptor) + Mod GRF 1-29 (GHRH)
Status
Investigational
Half-life
~15–60 min (GHRP-6) / ~30 min
Route
Subcutaneous
Dosing range in the literature
200–600 mcg total per dose
Onset
1–2 weeks
Storage
Refrigerated (2–8 °C); use within the pharmacy beyond-use date

How GHRP-6 + Mod GRF 1-29 works

Mod GRF 1-29 raises the amount of growth hormone released and GHRP-6 amplifies the pulse. GHRP-6 is less selective than newer peptides: it strongly increases hunger and can raise cortisol and prolactin.

What GHRP-6 + Mod GRF 1-29 is studied for

  • Growth hormone release
  • Appetite stimulation

Both compounds raise growth hormone in human studies. Neither has been developed into an approved medicine, and controlled outcome data is lacking.

Being studied for something is not proof that it works. Results in individuals vary.

GHRP-6 + Mod GRF 1-29 dosing

Published protocols describe 200–600 mcg total per dose, 1–3× daily, given subcutaneous. Onset is typically reported at 1–2 weeks.

These figures are context from the literature, not instructions. A licensed provider sets the dose and schedule for each patient.

GHRP-6 + Mod GRF 1-29 dosage calculator →

GHRP-6 + Mod GRF 1-29 side effects and risks

  • Strong hunger
  • Cortisol / prolactin rise
  • Water retention

Tell your provider about every medication and condition before starting, and report anything unexpected. See peptide side effects and safety and who should not use peptides.

Is GHRP-6 + Mod GRF 1-29 FDA approved?

Investigational. Neither component is FDA-approved.

Approval and trial status change. This page was last reviewed on October 1, 2026.

GHRP-6 + Mod GRF 1-29 at G1 Peptides

G1 Peptides does not currently supply GHRP-6 + Mod GRF 1-29. A provider can discuss alternatives in a free consultation.

GHRP-6 + Mod GRF 1-29 questions

What is GHRP-6 + Mod GRF 1-29?
A GHRP-6 and Mod GRF 1-29 blend combines two growth hormone secretagogues. GHRP-6 acts on the ghrelin receptor and Mod GRF 1-29 on the GHRH receptor, producing a strong pulse of growth hormone release.
What is GHRP-6 + Mod GRF 1-29 used for?
GHRP-6 + Mod GRF 1-29 is studied for growth hormone release and appetite stimulation. Both compounds raise growth hormone in human studies. Neither has been developed into an approved medicine, and controlled outcome data is lacking.
How does GHRP-6 + Mod GRF 1-29 work?
Mod GRF 1-29 raises the amount of growth hormone released and GHRP-6 amplifies the pulse. GHRP-6 is less selective than newer peptides: it strongly increases hunger and can raise cortisol and prolactin.
Is GHRP-6 + Mod GRF 1-29 FDA approved?
Investigational. Neither component is FDA-approved.
What is the typical GHRP-6 + Mod GRF 1-29 dosage?
Published protocols describe 200–600 mcg total per dose, given subcutaneous. This is context from the literature, not a recommendation: a licensed provider sets the dose.
What are the side effects of GHRP-6 + Mod GRF 1-29?
Risks noted for GHRP-6 + Mod GRF 1-29 include strong hunger, cortisol / prolactin rise, and water retention. Tell your provider about your medications and conditions before starting.
How long do the peptides in GHRP-6 + Mod GRF 1-29 last in the body?
The reported half-life is ~15–60 min (GHRP-6) / ~30 min. Onset is typically reported at 1–2 weeks.
How should GHRP-6 + Mod GRF 1-29 be stored?
Refrigerated (2–8 °C); use within the pharmacy beyond-use date.

For educational purposes only, and not medical advice. These statements have not been evaluated by the FDA. Nothing on this page is intended to diagnose, treat, cure, or prevent any disease. Use any compound only under the guidance of a licensed provider.